| Literature DB >> 33469985 |
Giulia Montalto1, Francesca Caudano1, Laura Sturla2, Santina Bruzzone2, Annalisa Salis2, Gianluca Damonte2, Jos Prickaerts3, Ernesto Fedele4,5, Roberta Ricciarelli1,5.
Abstract
Intraneuronal accumulation of hyperphosphorylated tau is a pathological hallmark of several neurodegenerative disorders, including Alzheimer's disease. Phosphorylation plays a crucial role in modulating the tau-microtubule interaction and the ability of the protein to aggregate, but despite efforts during the past decades, the real identity of the kynases involved in vivo remains uncertain. Here, for the first time, we demonstrate that the cGMP-dependent protein kinase G (PKG) phosphorylates tau in both in vitro and in vivo models. More intriguingly, we provide evidence that PKG phosphorylates tau at Ser214 but not at Ser202, a condition that could reduce the pathological aggregation of the protein shifting tau from a pro-aggregant to a neuroprotective anti-aggregant conformation.Entities:
Keywords: Alzheimer's disease; cGMP; phosphodiesterase 5 inhibitors; tau; vardenafil
Year: 2021 PMID: 33469985 DOI: 10.1002/biof.1705
Source DB: PubMed Journal: Biofactors ISSN: 0951-6433 Impact factor: 6.113